Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Randomized, Double-Blind Comparison of LY2216684 in Major Depressive Disorder
2008-002857-18Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing LY2216684 with Placebo (2 arms). Started Dec 2008; status: completed.
02
Drugs
edivoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-002857-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002857-18.